AMS sheds Laserscope aesthetics unit
This article was originally published in The Gray Sheet
Executive Summary
Iridex will pay $28 mil. for American Medical Systems' laser aesthetics business under a definitive agreement announced Nov. 30. Upon close of the deal, expected by Jan. 31, 2007, Iridex also will acquire $7.3 mil.-$9.5 mil. in net assets, including accounts receivable. AMS, which completed its $715 mil. acquisition of Laserscope in July, previously indicated that the laser device firm's aesthetics unit was not "a strategic fit" (1"The Gray Sheet" June 12, 2006, p. 10). Laserscope's aesthetics unit garnered $36.9 mil. in 2005 sales, roughly 30% of Laserscope's total 2005 sales of $127.1 mil. Iridex says the purchase will be immediately accretive to earnings...
You may also be interested in...
American Medical Buys Laserscope For GreenLight Obstructive BPH Treatment
American Medical Systems will expand its benign prostatic hyperplasia treatment offerings to include operating room-based obstructive BPH therapy with Laserscope's GreenLight surgical laser system under a June 5 acquisition agreement
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.